期刊文献+

Dbait基因联合放疗对A549细胞杀伤的实验研究 被引量:1

The experimental study of Dbait gene combined with radiotherapy on A549 cells
下载PDF
导出
摘要 目的:研究放疗联合Dbait基因对肿瘤A549细胞的杀伤作用。方法:培养好的A549细胞随机分为pcDNA3.1组和pcDNA3.1-Dbait组。将荷载相应基因的质粒通过Lipofectamine 2000转染A549细胞予以6MV-X线、剂量率300cGy/min,照射剂量6Gy。12小时后流式细胞仪检测肿瘤细胞凋亡率。结果:在非照射时两组间细胞凋亡率F=1.01,P=0.864;6Gy照射时两组间细胞凋亡率F=13.33,P=0.006,差异有统计学意义。结论:Dbait基因干扰DNA双链断裂的修复,联合放疗促进肿瘤细胞的凋亡。 Objective: To study the effect of Dbait gene combined with radiotherapy on A549 cells. Methods :The cultivated 3.549 cells were randomly divided into group pcDNA3.1 and pcDNA3.1 - Dbait. Corresponding plasmid transfected intod A549 ceils by Lipofectamine 2000. Medical hnear accelerator irradiated A549 cells,6MV -X, dose rate 300cGy/min, dose 6Gy. To detect apoptosis of tumor by flow cytometry after 12 hours. Results:When no -irradi- ation between the two groups apoptosis rate F = 1.01, P = 0. 864.6Gy irradiation between the two groups apoptosis rate F = 13.33, P = 0. 006. The difference was statistically significant. Conclusion: Dbait gene disrupt DNA double - strand break repair,combine with radiotherapy promote apoptosis of tumor cells.
出处 《现代肿瘤医学》 CAS 2013年第10期2205-2206,共2页 Journal of Modern Oncology
关键词 Dbait基因 放疗 A549细胞 Dbait gene radiotherapy A549 cells
  • 相关文献

参考文献10

  • 1Mafia Q, Nathalie B, Christophe R, et al. Small - molecule drugs mimicking DNA damage : a new strategy for sensitizing tumors to ra- diotherapy[J]. Clin Cancer Res,2009,15(4) :1308 - 1316.
  • 2Fischer U, Meese E. Glioblastoma multiforme : the role of DSB re- pair between genotype and phenotype [ J ]. Oneogene, 2007, 26 (56) :7809 -7815.
  • 3Rass K, Reiehrath J. UV damage and DNA repair in malignant mel- anoma and nonmelanoma skin cancer [ J ]. Adv Exp Med Biol, 2008,624 : 162 - 178.
  • 4Kanffmann A, Rosselli F, Lazar V, et al. High expression of DNA repair pathways is associated with metastasis in melanoma patients [ J ]. Oncogene ,2008,27 (5) :565 - 573.
  • 5Helleday T, Petermann E, Lundin C, et al. DNA repair pathways as targets for cancer therapy[ J]. Nat Rev Cancer,2008,8 ( 3 ) : 193 - 204.
  • 6Paull TT,Lee JH. The Mrel 1/Rad 50/Nbsl complex and its roles as a DNA double - strand break sensor for ATM [ J ]. Cell Cycle, 2005,4(8) :737 -740.
  • 7Pinto DM, Flaus A. Structure and function of histone H2AX [ J ]. Subcell Biochem ,2010,50:55 - 78.
  • 8Wasco MJ, Pu RT. Utility of antiphosphorylated H2AX antibody (gamma- H2AX)in diagnosing metastatic renal cell carcinoma [J]. Appl Imunohistochem Mol Morphol, 2008,16 (4):349 - 356.
  • 9Medvedeva NG, Panyutin IV, Panyutin IG, et al. Phosphorylation of histone H2AX in radiation- induced micronuclei [ J ]. Radiat Res, 2007,168(4) :493 -498.
  • 10Devun F, Bousquet G, Biau J, et al. Preelinical study of the DNA repair inhititor Dbait in combination with chemotherapy in colorec- tal cancer [ J ]. J Gastroentero1,2012,47 ( 3 ) :266 - 275.

同被引文献36

  • 1Peyromaure M, Debr6 B, Mao K, et al. Management of prostate cancer in China: a multicenter report of 6 institutions [ J ]. J Urol, 2005,174 (5) : 1794 - 1797.
  • 2Ghotra VP, Geldnf AA, Danen EH. Targeted radiosensitization in prostate cancer [ J]. Curt Pharm Des, 2013,19 ( 15 ) : 2819 - 2828.
  • 3laffoul J J, Sarkar FH, Hillman GG. Radiosensitization of prostate cancer by soy isoflavones [ Jl. Curr Cancer Drug Targets, 2007,7 (8) :759 -765.
  • 4Sasaki R, Shirakawa T, Zhang Z J, et al. Additional gene therapy with AdSCMV - p53 enhanced the efficacy of radiotherapy in hu- man prostate cancer cells [J]. Int J Radiat Oncol Biol Phys, 2001,51 (5) :1336 - 1345.
  • 5Cowen D, Salem N, Ashoori F, et al. Prostate cancer radiosensiti- zation in vivo with adenovirus - mediated p53 gene therapy [ J ]. Clin Cancer Res, 2000,6 ( 11 ) :4402 - 4408.
  • 6Watanabe T, Ichikawa A, Saito H, et al. Overexpression of the MDM2 oncogene in leukemia and lym~homa [ J] . Leuk Lympho- ma, 1996,21 (5-6) :391-397.
  • 7Freedman DA, Wu L, Levine AJ. Functions of the MDM2 oncop- rotein[ J ] . CellMol Life Sci, 1999, 55 (1) :96 - 107.
  • 8Juven -Gershon T, Oren M. MDM2: the ups and downs[ J]. Mol Meal,1999,5 (2) :71 -83.
  • 9Bianco R, Ciardiello F, Tortora G. Cherhosensitization by anti- sense oligonucleotides targeting MDM2 [ J 1. Curt Cancer Drug Targets ,2005,5(1) :51 -56.
  • 10Tanaka M, Rosser CJ, Grossman HB. PTEN gene therapy in-duces growth inhibition and increases efficacy of chemotherapy in prostate cancer [ J ]. Cancer Detect Prey, 2005,29 (2) : 170 - 174.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部